Latest News

For many, the main point of investing is to generate higher returns than the overall market. But the main game is to...

There wouldn't be many who think Arribatec Group ASA's ( OB:ARR ) price-to-sales (or "P/S") ratio of 0.8x is worth a...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Kimberly-Clark (KMB) has been quietly drifting lower this year, even as revenue and net income keep climbing. That disconnect between share price and fundamentals is exactly what makes the stock interesting now. See our latest analysis for Kimberly-Clark. The recent pullback, including a 1 month share price return of 4.27% after a much steeper 90 day share price decline of 19.21%, suggests sentiment is stabilising even as the 1 year total shareholder return of 21.18% remains under...

Victoria's Secret (VSCO) steps into Friday's earnings with expectations running high after last quarter's revenue beat, as investors weigh whether the retailer can balance growth ambitions against ongoing profitability and debt concerns. See our latest analysis for Victoria's Secret. That backdrop has helped fuel a sharp 90 day share price return of 58.36% and a 30 day share price return of 17.53%, even though the 1 year total shareholder return remains slightly negative. This suggests...

Kyoto Financial GroupInc (TSE:5844) just confirmed that, despite board approval for a sizeable share buyback program, it did not repurchase any stock during the late November window on the Tokyo market. See our latest analysis for Kyoto Financial GroupInc. The decision not to execute the buyback comes as Kyoto Financial GroupInc’s share price has climbed to ¥3,427, supported by a robust year to date share price return and a powerful multi year total shareholder return that suggest momentum is...

Key Insights CapitaLand Investment's significant private companies ownership suggests that the key decisions are...

Postal Savings Bank of China Co., Ltd. has approved a reshuffle of its board committees, declared an interim dividend of RMB 1.23 per 10 shares for the first half of 2025, and scheduled an extraordinary general meeting for December 19, 2025, to vote on profit distribution, remuneration, board authorization changes and a financial bond issuance plan. Together, the dividend announcement and governance adjustments highlight the bank’s focus on capital management, regulatory alignment and...

Recently, analysts have revised their earnings estimates for Silicon Laboratories upward for both the next quarter and the full year, reflecting greater confidence in the company’s profit outlook. This broad-based upgrade in expectations, paired with a strong Zacks Rank #2, points to potentially meaningful changes in how the company’s growth and earnings power are being assessed by the market. We’ll now examine how this recent wave of upward earnings revisions could reshape Silicon...

Toyo Seikan Group Holdings (TSE:5901) has kicked off a new chapter by investing in TOY MEDICAL, tying its packaging expertise to patented salt offset technology that targets healthier, lower salt diets without sacrificing taste. See our latest analysis for Toyo Seikan Group Holdings. The fresh TOY MEDICAL tie up comes as Toyo Seikan’s 1 month share price return of 12.81 percent builds on strong year to date momentum of 60.87 percent, supported by a striking 5 year total shareholder return of...

ImmunityBio (IBRX) just dropped around 9% as traders reposition ahead of its appearance at the Piper Sandler 37th Annual Healthcare Conference, even though Anktiva fueled sharp revenue growth last quarter. See our latest analysis for ImmunityBio. Despite today’s pullback, ImmunityBio’s 1 month share price return of 10.58 percent and 7 day gain of 7.98 percent suggest short term momentum is rebuilding, even though the 1 year total shareholder return of negative 49.67 percent shows long term...

Nutex Health (NUTX) has extended its share buyback plan through March 31, 2026, while also reopening its Red River ER and Hospital in Texas, pairing capital returns with on-the-ground growth. See our latest analysis for Nutex Health. Those moves come on the back of a sharp rerating in the stock, with the share price delivering a 351.58 percent year to date share price return, but a three year total shareholder return still negative at 55.71 percent. This suggests momentum is building off a...

TriMas Corporation has appointed Paul Swart as Chief Financial Officer, effective December 15, 2025, bringing over 25 years of financial leadership experience across TriMas, RealTruck and Ernst & Young. Swart’s combination of deep institutional knowledge from two decades at TriMas and hands-on experience integrating acquisitions could be especially important for the company’s ongoing portfolio optimization and financial transformation efforts. We’ll now examine how Swart’s track record in...

Why Olin Is Back on Value Investors Radar Olin (OLN) has slid nearly 40% this year, yet revenue and net income are still growing. This is forcing investors to rethink whether the recent share price drop has gone too far. See our latest analysis for Olin. The latest slide leaves Olin trading around $20.44, capping a roughly 39% year to date share price decline and an even steeper one year total shareholder return loss near 48%. This suggests sentiment has weakened despite improving...

Alkane Resources (ASX:ALK) has drawn fresh attention after appointing Denise McComish as an independent non executive director and Chair of the Audit and Risk Committee, a governance focused move that investors should not ignore. See our latest analysis for Alkane Resources. The timing of this governance upgrade lines up with a powerful year to date share price return of 97.17 percent and a 1 year total shareholder return just over 100 percent, suggesting momentum is still firmly with the...

Tokyu (TSE:9005) just lifted its interim dividend to JPY 14 per share from JPY 11 a year ago, a clear signal that management feels comfortable with cash flows and medium term earnings. See our latest analysis for Tokyu. The higher interim payout comes after a board meeting on a planned transfer of a specified subsidiary. The stock has delivered a 6.28 percent year to date share price return alongside a robust 5 year total shareholder return of 47.87 percent, suggesting steady but not...

In late November 2025, Asahi Group Holdings announced it was postponing the release of its FY2025 financial results after an October cyberattack disrupted its systems and delayed year‑end closing procedures and audits. This delay highlights how operational resilience and cybersecurity preparedness can become central issues for investors assessing a consumer staples group’s risk profile and disclosure reliability. We’ll now explore how the cyberattack‑driven postponement of Asahi’s earnings...

In the third quarter of 2025, SBA Communications reported adjusted funds from operations of US$3.30 per share, 10% year-over-year revenue growth, and expanded its tower portfolio through hundreds of site acquisitions and new builds across the Americas and Africa. Alongside this operational expansion, SBA Communications intensified capital returns by repurchasing 748,000 Class A shares for US$154.10 million and paying US$119.10 million in dividends, underscoring management’s focus on both...

Ascletis Pharma (SEHK:1672) just flagged a major pipeline milestone, selecting its in house, AI optimized ASC37 oral triple peptide agonist for clinical development in obesity, with an FDA IND filing targeted for 2026. See our latest analysis for Ascletis Pharma. That R&D breakthrough lands after a wild run in the stock, with a 1 month share price return of 42.97 percent and a massive 1 year total shareholder return of 663.58 percent, suggesting momentum is still very much alive. If this kind...

Worthington Enterprises (WOR) has been on a choppy stretch lately, with shares down about 15% over the past 3 months even as the stock still sits well ahead on a 1 year view. See our latest analysis for Worthington Enterprises. That pullback comes after a strong run, with the share price still showing a solid year to date gain and longer term total shareholder returns comfortably positive. This suggests momentum has cooled rather than completely reversing. If Worthington has you rethinking...

Primoris Services (PRIM) just landed on the radar as a top growth stock pick after earning a strong Zacks Rank and Growth Score, thanks to upbeat earnings revisions and expectations for above industry EPS growth. See our latest analysis for Primoris Services. That optimism is showing up in the chart too, with the share price now at $125.86 and a strong year to date share price return of 63.69 percent. This echoes the powerful multi year total shareholder returns that suggest momentum is still...

In December 2025, Bridgestone expanded its Potenza ultra-high performance tire range with the Potenza RE-71RZ, an extreme summer tire for grassroots racing that features ENLITEN technology, new performance compounds, a redesigned tread pattern and structural enhancements aimed at faster lap times, sharper handling and improved wear. By pairing motorsports-derived engineering with a focus on sustainability and premium niche positioning, the RE-71RZ strengthens Bridgestone’s push into...

Costamare (NYSE:CMRE) has quietly delivered a strong run, with the stock up about 26% over the past month and 35% in the past 3 months, despite declining annual revenue. See our latest analysis for Costamare. Zooming out, Costamare’s roughly 21% year to date share price return and powerful 1 year total shareholder return of about 73% suggest momentum is firmly building as investors reassess the company’s earnings resilience and asset values. If Costamare’s recent move has you thinking about...

Malakoff Corporation Berhad ( KLSE:MALAKOF ) shareholders have seen the share price descend 17% over the month. In...